Jonathan Emms Purchases 67,928 Shares of Circassia Group Plc (LON:CIR) Stock

Circassia Group Plc (LON:CIR) insider Jonathan Emms purchased 67,928 shares of the business’s stock in a transaction dated Thursday, April 1st. The shares were purchased at an average cost of GBX 29 ($0.38) per share, with a total value of £19,699.12 ($25,737.03).

Shares of LON CIR opened at GBX 29.70 ($0.39) on Thursday. The business has a 50 day simple moving average of GBX 26.96 and a 200 day simple moving average of GBX 26.26. Circassia Group Plc has a 52 week low of GBX 16.83 ($0.22) and a 52 week high of GBX 33.40 ($0.44). The stock has a market cap of £124.05 million and a price-to-earnings ratio of -3.38. The company has a debt-to-equity ratio of 2.42, a quick ratio of 0.89 and a current ratio of 1.11.

Circassia Group Company Profile

Circassia Group Plc, a specialty pharmaceutical company, focuses on the development and commercialization of respiratory products. It operates through three segments: NIOX, Chronic Obstructive Pulmonary Disease (COPD), and LungFit. The company markets NIOX and NIOX VERO for use in asthma diagnosis and management; Tudorza for the treatment of COPD; and Duaklir, a fixed-dose combination of the long-acting muscarinic antagonist aclidinium bromide and long-acting beta agonist formoterol fumarate, which is administered twice-daily through the breath actuated Pressair inhaler for the maintenance treatment of COPD.

See Also: ESG Score

Receive News & Ratings for Circassia Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Circassia Group and related companies with MarketBeat.com's FREE daily email newsletter.